Search
for
Sort by
Research 301–330 of 1000+
- The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- International collaboration and rapid harmonization across dermatologic COVID-19 registries
- Cultivation of Human Hair Follicle Cells
- The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases
- Cordyceps militaris Grown on Germinated Rhynchosia nulubilis (GRC) Encapsulated in Chitosan Nanoparticle (GCN) Suppresses Particulate Matter (PM)-Induced Lung Inflammation in Mice
- Human umbilical cord mesenchymal stem cell therapy for atopic dermatitis through inhibition of neutrophil chemotaxis
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Use of Complementary Alternative Medicine and Supplementation for Skin Disease
- Report: Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS.
- Periocular nasociliary lesion with elevated serum IgG4 levels: A case report on the risks of overdiagnosis in IgG4-related disease
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- IL-3 contributes to development of lupus nephritis in MRL/Ipr mice
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Biologics in the management of childhood atopic dermatitis
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Topical Alternatives for Hair Loss: Beyond the Conventional
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- The expression of equine keratins K42 and K124 is restricted to the hoof epidermal lamellae of Equus caballus
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Protective Effects of Melatonin on the Skin: Future Perspectives
- Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts
- Diet in dermatology: Revisited
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer